reallypeople, the trial designed protocol says that they will look into the S/C trial at 100 patients after either 14 or 28 days and I believe it's 28 days as the designed trial protocol states. No efficacy look at the 100 patients is part of that protocol design so they did not look at efficacy or anything else for that matter as well as they are not able to stop the trial either unless that trial was showing bad adverse effects and only then. Hope that clears it all up. IMO, that is what we were expecting from the looksee - GLTU

HCIT

RE:edited to show my addendum:

unless that trial was showing bad adverse effects and only then.